Key Proteo is democratizing the early detection of rare but treatable genetic disorders through novel and accessible proteomic analysis. As a pioneering proteomics company, Key Proteo is initially focused on the early detection of treatable rare genetic disorders in newborns, with the goal of expanding newborn screening to identify extremely low abundance protein biomarkers that were previously undetectable. Many treatable genetic disorders are difficult to detect, but when found early, intervention can be enabled to help change the clinical course. Ultimately, our mission is to relieve suffering and save lives for patients and their families afflicted by rare but treatable genetic disorders through early screening.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Seattle, Washington, Us
- Industry
- Medical Device
- Website
- https://www.keyproteo.com/
- Keywords
- 9mo.
- HQ
- Seattle, Washington
Key Proteo, Inc. Questions
Key Proteo, Inc.'s website is https://www.keyproteo.com/
Key Proteo, Inc.'s LinkedIn profile is https://www.linkedin.com/company/key-proteo-inc
Key Proteo, Inc. has
5 employees.
View email and phone details for 5
employees at Key Proteo, Inc..
Key Proteo, Inc.'s industry is
Medical Device
Key Proteo, Inc.'s top competitors are
Alveo Technologies,
Lynx Dx,
Arbormed,
Prime Medicine, Inc.,
Metalead,
Aggiosergeant International,
Isobiotics Ltd,
Altasciences,
Seattle Children's,
Baby Whisperers, Llc, Tm.
Key Proteo, Inc.'s categories are Medical Device
Key Proteo, Inc.'s founding year is 2019
